A detailed history of Spectrum Management Group, LLC transactions in Sab Biotherapeutics, Inc. stock. As of the latest transaction made, Spectrum Management Group, LLC holds 5,030 shares of SABS stock, worth $20,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,030
Holding current value
$20,069
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$0.13 - $12.4 $653 - $62,372
5,030 New
5,030 $4,000
Q4 2021

Feb 03, 2022

BUY
$7.3 - $11.24 $36,719 - $56,537
5,030 New
5,030 $39,000

Others Institutions Holding SABS

About SAB Biotherapeutics, Inc.


  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $172M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Spectrum Management Group, LLC Portfolio

Follow Spectrum Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Management Group, LLC with notifications on news.